The Zhitong Finance App learned that anti-cancer drug developer Summit Therapeutics (SMMT.US) announced that AstraZeneca (AZN.US) will make a strategic equity investment of 2 billion US dollars in it, and the two sides will jointly develop drugs. Boosted by this news, Summit's US stocks surged nearly 17% after the market on Monday as of press release.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.